Humacyte (HUMA) Prepaid Assets (2020 - 2026)
Humacyte (HUMA) posted quarterly Prepaid Assets of $4.7 million for Q1 2026, up 100.17% year-over-year from $2.4 million in Q1 2025, and up 43.94% quarter-over-quarter from $3.3 million in Q4 2025.
Humacyte (HUMA) Prepaid Assets (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Prepaid Assets for 7 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 100.17% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 100.17% YoY), while the FY2025 annual figure was $3.3 million, up 11.84% from the prior year.
- Prepaid Assets advanced to $4.7 million in Q1 2026 per HUMA's latest filing, from $3.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.0 million in Q2 2023 and bottomed at $2.2 million in Q1 2023.
- Historically, Prepaid Assets has averaged $2.9 million across 5 years, with a median of $2.7 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 3293.76% — and 2024, when it slumped 57.25%.
- Humacyte's Prepaid Assets stood at $2.3 million in 2022, then advanced by 23.15% to $2.8 million in 2023, then advanced by 3.25% to $2.9 million in 2024, then advanced by 11.84% to $3.3 million in 2025, then soared by 43.94% to $4.7 million in 2026.
- Business Quant data shows HUMA's Prepaid Assets at $4.7 million in Q1 2026, $3.3 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Humacyte | 155.52 Mn | 155.52 Mn | -825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.57 Mn |
| Mar 31, 2026 | 4.70 Mn |
| Dec 31, 2025 | 3.27 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 2.87 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 2.69 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 3.49 Mn |